Analytical comparison of the cobas HPV test with hybrid capture 2 for the detection of high-risk HPV genotypes

Journal of Molecular Diagnostics

Volumn 14, Issue 1, 2012, Pages 65-70

  Mateos Lindemann, Maria Luisa ^a   Rodriguez Dominguez, Mario Jose ^a   Chacón De Antonio, Jesús ^a   Sandri, Maria Teresa ^b   Tricca, Alessio ^b   Sideri, Mario ^b   Khiri, Hacène ^c   Ravet, Sophie ^c   Boyle, Sean ^d   Aldrich, Carrie ^d   Halfon, Philippe ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c Laboratoire Alphabio   (France)

^d ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; COBAS HPV TEST; CROSS REACTION; DIAGNOSTIC TEST; DNA DETERMINATION; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HYBRID; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; MEDICAL RECORD REVIEW; PREDICTIVE VALUE; RETROSPECTIVE STUDY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84555189574     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2011.09.005     Document Type: Article

References (24)

1. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, K.V. Shah Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group J Natl Cancer Inst 87 1995 796 802
2. M.H. Schiffman, H.M. Bauer, R.N. Hoover, A.G. Glass, D.M. Cadell, B.B. Rush, D.R. Scott, M.E. Sherman, R.J. Kurman, S. Wacholder, C.K. Stanton, M.M. Manos Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia J Natl Cancer Inst 85 1993 958 964 (Pubitemid 23177581)
3. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, N. Munoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19 (Pubitemid 29406813)
4. J. Cuzick, C. Clavel, K.U. Petry, C.J. Meijer, H. Hoyer, S. Ratnam, A. Szarewski, P. Birembaut, S. Kulasingam, P. Sasieni, T. Iftner Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 2006 1095 1101 (Pubitemid 44116919)
5. M.H. Mayrand, E. Duarte-Franco, I. Rodrigues, S.D. Walter, J. Hanley, A. Ferenczy, S. Ratnam, F. Coutlee, E.L. Franco Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588 (Pubitemid 47598400)
6. J. Jordan, M. Arbyn, P. Martin-Hirsch, U. Schenck, J.J. Baldauf, D. Da Silva, A. Anttila, P. Nieminen, W. Prendiville European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1 Cytopathology 19 2008 342 354
7. T.C. Wright Jr, L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, D. Solomon 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests Am J Obstet Gynecol 197 2007 346 355 (Pubitemid 47464164)
8. F.X. Bosch, S. de Sanjose Chapter 1: Human papillomavirus and cervical cancer burden and assessment of causality J Natl Cancer Inst Monogr 2003 3 13
9. N.F. Munoz, X. Bosch, R. de, S.S. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders, C.J. Meijer Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527 (Pubitemid 36159887)
10. M.J. Khan, P.E. Castle, A.T. Lorincz, S. Wacholder, M. Sherman, D.R. Scott, B.B. Rush, A.G. Glass, M. Schiffman The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice J Natl Cancer Inst 97 2005 1072 1079 (Pubitemid 41417924)
11. M.H. Stoler, T.C. Wright Jr, A. Sharma, R. Apple, K. Gutekunst, T.L. Wright ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group High-risk human papillomavirus testing in women with ASC-US cytology Results from the ATHENA HPV Study Am J Clin Pathol 135 2011 468 475
12. T.C. Wright Jr, M.H. Stoler, A. Sharma, G. Zhang, C. Behrens, T.L. Wright ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group Evaluation of HPV-16 and HPV-18 genotyping for the triage of high-risk HPV+ cytology-negative women Am J Clin Path 136 2011 578 586
13. HC2 high-risk HPV DNA test 2008 Qiagen Gaithersburg, MD [package insert]
14. cobas HPV Test 2011 Roche Molecular Systems Inc. Branchburg, NJ [package insert]
15. Linear array HPV genotyping test 2008 Roche Molecular Systems Inc. Branchburg, NJ [package insert]
16. P.E. Castle, M. Schiffman, R.D. Burk, S. Wacholder, A. Hildesheim, R. Herrero, M.C. Bratti, M.E. Sherman, A. Lorincz Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types Cancer Epidemiol Biomarkers Prev 11 2002 1394 1399 (Pubitemid 35340375)
17. P.E. Castle, D. Solomon, C.M. Wheeler, P.E. Gravitt, S. Wacholder, M. Schiffman Human papillomavirus genotype specificity of hybrid capture 2 J Clin Microbiol 46 2008 2595 2604
18. M. Poljak, A. Kovanda, B.J. Kocjan, K. Seme, N. Jancar, E. Vrtacnik-Bokal The Abbott real time high risk HPV test: comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the hybrid capture 2 HPV DNA test Acta Dermatovenerol Alp Panonica Adriat 18 2009 94 103
19. M. Poljak, I.J. Marin, K. Seme, A. Vince Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail J Clin Virol 25 Suppl 3 2002 S89 S97
20. M.T. Sandri, P. Lentati, E. Benini, P. Dell'Orto, L. Zorzino, F.M. Carozzi, P. Maisonneuve, R. Passerini, M. Salvatici, C. Casadio, S. Boveri, M. Sideri Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples J Clin Microbiol 44 2006 2141 2146 (Pubitemid 43902166)
21. P.E. Castle, M. Sadorra, T. Lau, C. Aldrich, F.A. Garcia, J. Kornegay Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping J Clin Microbiol 47 2009 3344 3347
22. M. Schiffman, M.J. Khan, D. Solomon, R. Herrero, S. Wacholder, A. Hildesheim, A.C. Rodriguez, M.C. Bratti, C.M. Wheeler, R.D. Burk A study of the impact of adding HPV types to cervical cancer screening and triage tests J Natl Cancer Inst 97 2005 147 150 (Pubitemid 40277095)
23. C.J. Meijer, J. Berkhoff, P.E. Castle, A.T. Hesselink, E.L. Franco, G. Ronco, M. Arbyn, F.X. Bosch, J. Cuzick, J. Dillner, D.A. Heideman, P.J. Snijders Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older Int J Cancer 124 2009 516 520
24. D.A.M. Heideman, A.T. Hesselink, J. Berkhof, F. van Kemenade, W.J.G. Melchers, N. Fransen Daalmeijer, M. Verkuijten, C.J.L.M. Meijer, P.J.F. Snijders Clinical validation of the cobas 4800 HPV Test for cervical screening purposes J Clin Microbiol 2011 10.1128/JCM.05552-11